✦ LIBER ✦

314 VIUSID, A NUTRITIONAL SUPPLEMENT, IN PATIENTS WITH CHRONIC HEPATITIS C AND CIRRHOSIS. A RANDOMIZED AND CONTROLLED STUDY

✍ Scribed by E. Vilar Gomez; Y. Sanchez Rodriguez; E. Arus Soler; B. Gra Oramas

Book ID: 117376240
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 51 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60316-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Viusid, a nutritional supplement, in com

Viusid, a nutritional supplement, in combination with interferon α-2b and ribavirin in patients with chronic hepatitis C

✍ Eduardo Vilar Gomez; Bienvenido Gra Oramas; Enrique Arus Soler; Raimundo Llanio 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Clinical trial: a nutritional supplement

Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease

✍ E. VILAR GOMEZ; A. RODRIGUEZ DE MIRANDA; B. GRA ORAMAS; E. ARUS SOLER; R. LLANIO 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Peginterferon alfa-2b and ribavirin in p

Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study

✍ Angelo Iacobellis; Massimo Siciliano; Francesco Perri; Brigida E. Annicchiarico; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Nutritional assesment of patients with c

Nutritional assesment of patients with chronic hepatitis B and C

✍ G. Kulig; A. Boroń; Z Sych 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 166 KB

P.264 Viusid in combination with interfe

P.264 Viusid in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. Efficacy and safety results from a ramdomized controlled trial

✍ E. Vilar Gómez; B. Grá; E. Arús Soler; C. Ruenes Domech; Y. Betancourt 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Risk factors for cirrhosis in patients w

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study

✍ L Serfaty; O Chazouilleres; A Poujol-Robert; L Morand-Joubert; C Dubois; Y Chret 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 3 views

even moderate, is a risk factor for cirrhosis. (HEPATOLOGY The role of the viral genotype, especially genotype 1b, in 1997;26:776-779.) the severity of liver injury induced by chronic hepatitis C virus (HCV) infection is unclear, probably because of confounding factors such as the date and mode of c